462 related articles for article (PubMed ID: 21516018)
21. Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.
Filippi L; Tamburini A; Berti E; Perrone A; Defilippi C; Favre C; Calvani M; Della Bona ML; la Marca G; Donzelli G
Pediatr Blood Cancer; 2016 Jul; 63(7):1290-2. PubMed ID: 27100060
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
23. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
24.
Russell TB; Rinker EK; Dillingham CS; Givner LB; McLean TW
Pediatrics; 2018 Apr; 141(Suppl 5):S421-S424. PubMed ID: 29610164
[TBL] [Abstract][Full Text] [Related]
25. Kaposiform hemangioendothelioma: a rare cause of spontaneous hemothorax in infancy. Review of the literature.
San Miguel FL; Spurbeck W; Budding C; Horton J
J Pediatr Surg; 2008 Jan; 43(1):e37-41. PubMed ID: 18206444
[TBL] [Abstract][Full Text] [Related]
26. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
27. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D.
Hu B; Lachman R; Phillips J; Peng SK; Sieger L
J Pediatr Hematol Oncol; 1998; 20(6):567-9. PubMed ID: 9856681
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of retroperitoneal infantile hemangioendothelioma with Kasabach-Merritt syndrome using steroid, alpha-interferon, and vincristine.
Yoon HS; Lee JH; Moon HN; Seo JJ; Im HJ; Goo HW
J Pediatr Hematol Oncol; 2009 Dec; 31(12):952-4. PubMed ID: 19875968
[TBL] [Abstract][Full Text] [Related]
29. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
30. Kaposiform hemangioendothelioma: a locally aggressive vascular tumor.
Beaubien ER; Ball NJ; Storwick GS
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):799-802. PubMed ID: 9591789
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic features of kaposiform hemangioendothelioma].
Tang HF; Zhou YY; Gu WZ; Li MJ
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1132-5. PubMed ID: 15498303
[TBL] [Abstract][Full Text] [Related]
32. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.
Haisley-Royster C; Enjolras O; Frieden IJ; Garzon M; Lee M; Oranje A; de Laat PC; Madern GC; Gonzalez F; Frangoul H; Le Moine P; Prose NS; Adams DM
J Pediatr Hematol Oncol; 2002; 24(6):459-62. PubMed ID: 12218593
[TBL] [Abstract][Full Text] [Related]
33. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.
Deb G; Jenkner A; De Sio L; Boldrini R; Bosman C; Standoli N; Donfrancesco A
Med Pediatr Oncol; 1997 May; 28(5):358-61. PubMed ID: 9121401
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
35. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen.
Hauer J; Graubner U; Konstantopoulos N; Schmidt S; Pfluger T; Schmid I
Pediatr Blood Cancer; 2007 Nov; 49(6):852-4. PubMed ID: 16411198
[TBL] [Abstract][Full Text] [Related]
36. Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy.
Vin-Christian K; McCalmont TH; Frieden IJ
Arch Dermatol; 1997 Dec; 133(12):1573-8. PubMed ID: 9420544
[TBL] [Abstract][Full Text] [Related]
37. Multifocal kaposiform hemangioendothelioma in multiple visceral organs: an autopsy of 9-day-old female baby.
Nakaya T; Morita K; Kurata A; Ushiku T; Igarashi T; Kuroda M; Fukayama M
Hum Pathol; 2014 Aug; 45(8):1773-7. PubMed ID: 24931465
[TBL] [Abstract][Full Text] [Related]
38. Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma.
Drucker AM; Pope E; Mahant S; Weinstein M
J Cutan Med Surg; 2009; 13(3):155-9. PubMed ID: 19426625
[TBL] [Abstract][Full Text] [Related]
39. Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis.
Blei F
Pediatr Blood Cancer; 2015 Apr; 62(4):551-2. PubMed ID: 25559734
[No Abstract] [Full Text] [Related]
40. Rapidly involuting congenital hemangioma associated with profound, transient thrombocytopenia.
Rangwala S; Wysong A; Tollefson MM; Khuu P; Benjamin LT; Bruckner AL
Pediatr Dermatol; 2014; 31(3):402-4. PubMed ID: 22937785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
